| Sympathetic inhibition with clonidine improves autonomic balance in congestive heart failure. | |
| | |
MedLine Citation:
|
PMID: 9158165 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In this double-blind, placebo-controlled crossover study, we examined the effect of transdermal clonidine (given for 5 days) on autonomic control in 14 patients with mild to moderate congestive heart failure by heart rate variability analysis. Compared with placebo, clonidine increased the 24-h mean R-R interval from 718+/-110 to 811+/-117 ms (P<0.01), increased the S.D. of all normal RR intervals (SDNN) from 60.8+/-18.5 to 80.9+/-21.4 ms (P<0.01), the S.D. of the average RR intervals for all 5-min segments (SDANN) from 54.7+/-15.2 to 70.5+/-18.4 ms (P<0.01) and the mean of the S.D.s of all RR intervals for all 5-min segments (SDNN index) from 29.2+/-8.3 to 36.5+/-8.1 ms (P<0.01). The root mean square successive differences (r-MSSD) and the percent of differences between adjacent RR intervals >50 ms (pNN50) were also increased from 18.3+/-6.7 to 23.1+/-7.0 ms (P<0.01) and from 2.1+/-1.9 to 4.5+/-3.0% (P<0.01). In addition, total power, low frequency power and high frequency power were increased from 641+/-322 to 898+/-403 ms2/Hz (P<0.01), from 149+/-97 to 216+/-133 ms2/Hz (P<0.01) and from 52.8+/-27.1 to 93.2+/-41.3 ms2/Hz (P<0.01), respectively. The plasma norepinephrine level was decreased significantly from 0.52+/-0.18 to 0.24+/-0.09 ng/ml (P<0.01) after clonidine therapy. Changes in heart rate variability measures after clonidine administration were positively related to changes in plasma norepinephrine level. These results indicate that suppressing the sympathetic nervous system by clonidine improves autonomic balance in patients with congestive heart failure. But whether such restoration of the autonomic control has a beneficial effect on the long-term management of these patients still needs further investigation. |
| | |
Authors:
|
Z You-hua; S You-cheng; Z Jun; Y Xian-qi |
Related Documents
:
|
2708545 - Blood pressure and blood pressure variability following withdrawal of propranolol and c... 2565395 - Time-dependent enhancement of xylazine-induced, alpha-2 adrenoceptor-mediated vasoconst... 2620475 - Centrally acting alpha-2 agonists, peripherally acting adrenergic-blocking drugs, and d... 8413455 - The diagnosis and treatment of baroreflex failure. 2077175 - Heart-rate-proportional oxygen consumption for constant cardiac work in dog heart. 2943685 - Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative pa... |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: International journal of cardiology Volume: 59 ISSN: 0167-5273 ISO Abbreviation: Int. J. Cardiol. Publication Date: 1997 Apr |
Date Detail:
|
Created Date: 1997-06-10 Completed Date: 1997-06-10 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8200291 Medline TA: Int J Cardiol Country: IRELAND |
Other Details:
|
Languages: eng Pagination: 139-44 Citation Subset: IM |
Affiliation:
|
Department of Cardiology, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences, Beijing, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Cutaneous Adrenergic Agonists / administration & dosage, therapeutic use* Adult Aged Autonomic Nervous System / drug effects, physiopathology* Clonidine / administration & dosage, therapeutic use* Cross-Over Studies Double-Blind Method Female Heart Failure / drug therapy*, physiopathology Heart Rate / drug effects Humans Male Middle Aged Norepinephrine / blood Pilot Projects Placebos Sympathetic Nervous System / drug effects Sympatholytics / administration & dosage, therapeutic use* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic Agonists; 0/Placebos; 0/Sympatholytics; 4205-90-7/Clonidine; 51-41-2/Norepinephrine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Serum basic fibroblast growth factor levels in patients with ischemic heart disease.
Next Document: Relationship between isokinetic muscle strength and exercise capacity in chronic heart failure.